Evidence map›Paper›PMID 34734494›Full record

ArticleObesity (Silver Spring, Md.)2021

A role for the early pregnancy maternal milieu in the intergenerational transmission of obesity.

Emily W Flanagan, Jasper Most, Abby D Altazan, Kristen E Boyle, Leanne M Redman

Open access · greenAbstract read
In one paragraph

Article in Obesity (Silver Spring, Md.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Emily W FlanaganPennington Biomedical Research Center, Baton Rouge, Louisana, USA.ORCID 0000-0001-9496-5257
Jasper MostZuyderland Medical Center, Sittard/Geleen, the Netherlands.ORCID 0000-0001-8591-5629
Abby D AltazanPennington Biomedical Research Center, Baton Rouge, Louisana, USA.ORCID 0000-0001-7388-823X
Kristen E BoyleUniversity of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.ORCID 0000-0001-9689-3322
Leanne M RedmanPennington Biomedical Research Center, Baton Rouge, Louisana, USA.ORCID 0000-0002-7267-7374
Pennington Biomedical Research Center · USUniversity of Colorado Anschutz Medical Campus · USZuyderland Medisch Centrum · NL

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Leigh Lamonica · 2012 to 2026
$69.1M
Research BaseP30DK072476 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Sujoy Ghosh · 2005 to 2026
$26.5M
A pragmatic, scalable e-health intervention for management of gestational weight gain in low-income mothersR01NR017644 · NINR · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI REDMAN, LEANNE MAREE · 2019 to 2024
$3.6M
Promoting fat loss during pregnancy in women with grade 2 and 3 obesityR01DK124806 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI PHELAN, SUZANNE, REDMAN, LEANNE MAREE · 2020 to 2024
$3.2M
Determinants of gestational weight gain in obese pregnant womenR01DK099175 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI REDMAN, LEANNE MAREE · 2013 to 2015
$1.8M
Epigenetic programming of infant mesenchymal stem cells: mechanisms for obesity and diabetes risk in humansR01DK117168 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI BOYLE, KRISTEN ELIZABETH · 2018 to 2022
$1.7M
NIDDK NIH HHS P30 DK072476NIDDK NIH HHS R01 DK099175NIDDK NIH HHS R01 DK117168NIDDK NIH HHS R01 DK124806NIGMS NIH HHS U54 GM104940NINR NIH HHS R01 NR017644
6 · The paper itself

Abstract

objectiveMaternal obesity increases the risks for adverse pregnancy and offspring outcomes but with large heterogeneity. This study examined changes to the maternal metabolic milieu across pregnancy in women with obesity. It identified differences between a metabolically unhealthy obesity (MUO) phenotype and a metabolically healthy obesity (MHO) phenotype, as well as the differences in offspring adiposity between the two metabolic phenotypes.

methodsIn early pregnancy, women were classified with MHO (n = 13) or MUO (n = 9) based on the presence of zero or ≥2 risk factors for metabolic syndrome, respectively (systolic blood pressure > 130 mm Hg or diastolic blood pressure > 85 mm Hg, HDL cholesterol < 50 mg/dL, LDL cholesterol ≥ 100 mg/dL, triglycerides ≥ 150 mg/dL, and glucose ≥ 100 mg/dL). Area under the pregnancy concentration curve for glucose and triglycerides measured at early (13-16 weeks), mid- (24-27 weeks), and late (35-37 weeks) pregnancy, gestational weight gain (GWG), energy expenditure, maternal fat accretion, and infant body composition were compared.

resultsMaternal BMI, GWG, and fat accretion did not differ between MUO and MHO. Women with MUO had a greater area under the pregnancy concentration curve for glucose (+2,170 [382] mg/dL·day, p < 0.001) and triglycerides (+12,211 [3,916] mg/dL·day, p < 0.001). There were no differences in late-pregnancy total daily energy expenditure, but activity energy expenditure was significantly lower in MUO (-403 [144] kcal). MUO offspring had greater weight (+621 [205] g, p = 0.01) and adiposity (+5.8% [2.1%], p = 0.02) at 1 week of life but showed no differences in fat-free mass.

conclusionsIndependent of GWG, MUO resulted in heightened exposure of fetal fat-promoting substrates. Differing metabolic phenotypes may explain heterogeneity of offspring adiposity born to women with obesity.

Indexed as

Metabolic SyndromeObesity, Metabolically BenignAdiposityBody Mass IndexFemaleHumansObesityPregnancyRisk Factors

Identifiers

PMID34734494
PMCPMC9208317
OpenAlexW3211241307

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.